Group One Trading’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $970K | Buy |
+6,959
| New | +$975K | ﹤0.01% | 2755 |
|
|
2025
Q3 | – | Sell |
-18,791
| Closed | -$2.14M | – | 8648 |
|
|
2025
Q2 | $2.08M | Buy |
+18,791
| New | +$2M | ﹤0.01% | 2097 |
|
|
2024
Q1 | – | Sell |
-13,325
| Closed | -$1.02M | – | 7367 |
|
|
2023
Q4 | $1.08M | Buy |
+13,325
| New | +$1.04M | ﹤0.01% | 2399 |
|
|
2022
Q4 | – | Sell |
-61,265
| Closed | -$4.85M | – | 7537 |
|
|
2022
Q3 | $3.78M | Buy |
61,265
+56,958
| +1,322% | +$3.59M | 0.01% | 1389 |
|
|
2022
Q2 | $266K | Sell |
4,307
-375,243
| -99% | -$23.2M | ﹤0.01% | 4020 |
|
|
2022
Q1 | $22.6M | Sell |
379,550
-2,955
| -0.8% | -$189K | 0.02% | 551 |
|
|
2021
Q4 | $27.8M | Buy |
382,505
+347,229
| +984% | +$23.9M | 0.02% | 521 |
|
|
2021
Q3 | $2.46M | Sell |
35,276
-877,726
| -96% | -$61.7M | ﹤0.01% | 2439 |
|
|
2021
Q2 | $62.9M | Buy |
913,002
+163,443
| +22% | +$10.9M | 0.08% | 201 |
|
|
2021
Q1 | $48.4M | Buy |
749,559
+18,022
| +2% | +$1.16M | 0.07% | 226 |
|
|
2020
Q4 | $42.6M | Buy |
+731,537
| New | +$44.1M | 0.07% | 225 |
|
|
2020
Q1 | – | Sell |
-156,271
| Closed | -$10.8M | – | 5430 |
|
|
2019
Q4 | $10.2M | Sell |
156,271
-18,998
| -11% | -$1.24M | 0.07% | 337 |
|
|
2019
Q3 | $11.1M | Sell |
175,269
-19,714
| -10% | -$1.29M | 0.09% | 241 |
|
|
2019
Q2 | $13.2M | Buy |
194,983
+33,282
| +21% | +$2.19M | 0.12% | 170 |
|
|
2019
Q1 | $10.5M | Buy |
161,701
+18,848
| +13% | +$1.25M | 0.12% | 186 |
|
|
2018
Q4 | $8.94M | Buy |
142,853
+79,003
| +124% | +$5.52M | 0.08% | 289 |
|
|
2018
Q3 | $4.93M | Sell |
63,850
-47,709
| -43% | -$3.6M | 0.04% | 592 |
|
|
2018
Q2 | $7.9M | Buy |
111,559
+37,528
| +51% | +$2.65M | 0.07% | 334 |
|
|
2018
Q1 | $5.58M | Sell |
74,031
-119,657
| -62% | -$9.51M | 0.06% | 413 |
|
|
2017
Q4 | $13.9M | Buy |
193,688
+104,608
| +117% | +$7.94M | 0.1% | 236 |
|
|
2017
Q3 | $7.22M | Sell |
89,080
-114,776
| -56% | -$8.78M | 0.07% | 370 |
|
|
2017
Q2 | $14.4M | Sell |
203,856
-3,091
| -1% | -$206K | 0.15% | 138 |
|
|
2017
Q1 | $14.1M | Buy |
206,947
+32,558
| +19% | +$2.29M | 0.16% | 120 |
|
|
2016
Q4 | $12.5M | Buy |
174,389
+35,323
| +25% | +$2.63M | 0.12% | 172 |
|
|
2016
Q3 | $11M | Buy |
139,066
+53,584
| +63% | +$4.35M | 0.12% | 165 |
|
|
2016
Q2 | $7.13M | Sell |
85,482
-4,238
| -5% | -$376K | 0.08% | 261 |
|
|
2016
Q1 | $8.24M | Buy |
89,720
+726
| +0.8% | +$65.5K | 0.12% | 182 |
|
|
2015
Q4 | $9.01M | Buy |
88,994
+37,642
| +73% | +$3.92M | 0.11% | 190 |
|
|
2015
Q3 | $5.04M | Sell |
51,352
-11,467
| -18% | -$1.27M | 0.07% | 350 |
|
|
2015
Q2 | $7.36M | Sell |
62,819
-23,827
| -27% | -$2.6M | 0.1% | 210 |
|
|
2015
Q1 | $8.5M | Buy |
86,646
+12,222
| +16% | +$1.24M | 0.13% | 127 |
|
|
2014
Q4 | $7.01M | Buy |
74,424
+74,024
| +18,506% | +$7.66M | 0.11% | 190 |
|
|
2014
Q3 | $43K | Buy |
+400
| New | +$39.2K | ﹤0.01% | 3623 |
|
|
2014
Q2 | – | Sell |
-3,300
| Closed | -$234K | – | 5273 |
|
|
2014
Q1 | $234K | Buy |
+3,300
| New | +$259K | ﹤0.01% | 2315 |
|
Other funds holding GILD
VCM
VPM
Group One Trading's GILD Position: Q1 2026 in Review
Group One Trading opened a new position in Gilead Sciences (GILD) in Q1 2026: 6,959 shares worth $970K. The stake represents ﹤0.01% of the portfolio and ranks #2755 among its holdings. This is a return to the name: Group One Trading previously reported a position in GILD as recently as Q2 2025.
Group One Trading first reported a position in GILD in Q1 2014 and has held it in 34 quarters since. The position peaked at $62.9M in Q2 2021. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Group One Trading held 6,959 shares of Gilead Sciences worth $970K as of Q1 2026.
- Gilead Sciences was a new Group One Trading position in Q1 2026.
- Gilead Sciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2755 holding.
- Group One Trading first reported a position in Gilead Sciences in Q1 2014 and has held it in 34 quarters since.
- Group One Trading's Gilead Sciences position peaked at $62.9M in Q2 2021.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.